金盘科技公告，截至2025年9月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购 公司股份95.9万股，占总股本的比例为0.21%，成交总金额为人民币3000.84万元，价格区间为30.31元/ 股~32.68元/股。公司预计回购金额在3000万元~5000万元之间，回购股份将用于员工持股计划或股权激 励。 ...

Core Viewpoint - Anhui Xinruida Technology Co., Ltd. has approved a share repurchase plan to utilize 10 million to 20 million yuan of its own or special loan funds for equity incentives, adjusting the repurchase price ceiling due to the 2024 annual equity distribution [1] Group 1 - The company plans to repurchase shares using 10 million to 20 million yuan for equity incentives [1] - The repurchase price ceiling has been adjusted from 26.96 yuan/share to 26.71 yuan/share starting July 10 [1] - As of September 30, the company has repurchased a total of 187,900 shares, accounting for 0.0841% of the total share capital [1] Group 2 - The highest transaction price during the repurchase was 19.86 yuan/share, while the lowest was 19.747 yuan/share [1] - The total amount spent on the repurchase so far is 3,721,901.80 yuan, sourced from the company's own funds [1]

Core Viewpoint - The board of Aurite Pharmaceutical Co., Ltd. has approved a share repurchase plan to buy back shares through centralized bidding, with a budget of 60 million to 120 million yuan for the purpose of converting the company's convertible bonds [1] Summary by Relevant Sections - **Repurchase Plan Details** - The repurchase amount is set between 60 million and 120 million yuan, with a repurchase period of 12 months [1] - The upper limit for the repurchase price was originally not to exceed 25 yuan per share, adjusted to not exceed 24.71 yuan per share after equity distribution [1] - **Current Repurchase Status** - As of September 30, the company has repurchased a total of 1,746,738 shares, accounting for 0.43% of the total share capital [1] - The total funds paid for the repurchase amount to 35,607,509.68 yuan, with a repurchase price range between 18.83 and 22.59 yuan per share [1]

浙江奥翔药业股份有限公司发布以集中竞价交易方式回购公司股份进展公告。回购方案首次披露于2025 年1月27日，实施期限为2025年1月24日至2026年1月23日，预计回购金额5000万元 - 10000万元，用于股 权激励和/或员工持股计划。截至2025年9月30日，公司累计回购股份5,201,200股，占总股本比例 0.63%，已支付总金额50,006,023.36元，实际回购价格区间为7.52元/股 - 11.39元/股。2025年9月未实施 股份回购。 ...

2025年3月15日，南京医药首次披露回购方案，实施期限为2025年3月14日至2026年3月14日，预计回购 金额7000万元至13158万元，用于员工持股计划或股权激励。截至2025年9月30日，公司已累计回购股份 1629.9951万股，占总股本1.25%，累计已回购金额8025.76万元，实际回购价格区间为4.69元/股至5.22 元/股。因"南药转债"转股，公司9月末总股本有所增加。本次回购符合规定，公司将按规实施并及时披 露信息。 ...

Core Points - The company announced a share repurchase plan approved at the shareholders' meeting on May 16, 2025, with a repurchase period from May 16, 2025, to November 14, 2025 [1] - The expected repurchase amount is between 50 million to 100 million yuan, aimed at reducing registered capital [1] - As of September 30, the company has repurchased a total of 6 million shares, accounting for 0.86% of the total share capital, with a maximum transaction price of 6.65 yuan per share and a minimum of 6.30 yuan per share, totaling a payment of 38,878,040 yuan [1]

三一重工（证券代码：600031）发布以集中竞价交易方式回购公司股份的进展公告。回购方案首次披露 于4月4日，实施期限为2025年4月3日至2026年4月2日，预计回购金额10亿元至20亿元，用于员工持股计 划。截至2025年9月底，公司累计回购股份7,267.92万股，占总股本的0.86%，购买最高价为19.39元/ 股、最低价为17.39元/股，已支付总金额135,536.87万元。9月未实施股份回购，公司将依规在期限内择 机回购并及时披露信息。 ...

Group 1 - The company, Qianwei Yangchu (001215.SZ), has announced a share buyback program, having repurchased a total of 248,500 shares, which represents 0.26% of its total share capital [1] - The highest transaction price during the buyback was 39.73 CNY per share, while the lowest was 32.35 CNY per share [1] - The total amount spent on the buyback reached 8,991,611 CNY, excluding transaction fees [1]

Core Points - The company has repurchased a total of 362,900 shares as of September 30, 2025, which represents 0.36% of its total share capital [1] - The highest purchase price was 41.01 CNY per share, while the lowest was 34.36 CNY per share, with a total expenditure of 13.9267 million CNY [1] - The company plans to use its own funds and self-raised funds for share repurchase through centralized bidding, with an expected repurchase amount between 30 million CNY and 50 million CNY [1]

2025年6月23日，日联科技董事会审议通过以集中竞价交易方式回购股份方案，回购资金1000万 - 2000 万元，期限自当日起12个月，原回购价上限101.87元/股，因权益分派调整为不超70.03元/股。9月，公 司累计回购87,149股，支付资金509.32万元。截至9月30日，累计回购195,604股，占总股本0.1181%，支 付资金1009.31万元，成交价格45.94 - 60元/股。公司将依规择机回购并及时披露信息。 ...